The low density lipoprotein (LDL) receptors in fibroblasts from 132 subjects with the clinical syndrome of homozygous familial hypercholesterolemia were analyzed by immunoprecipitation with an anti-LDL receptor monoclonal antibody. 16 of the 132 cell strains (12%) synthesized no immunodetectable LDL receptor protein, indicating the presence of two mutant genes that failed to produce cross-reacting material (crm-mutations). DNA and mRNA from 15 of the 16 cram patients, representing 30 crm genes, were available for further study. Haplotype analysis based on 10 restriction fragment length polymorphisms (RFLPs) suggested that the 30 crnf genes represent 13 mutant alleles. Four of the alleles produced no mRNA. Three of these four mRNA-alleles had large deletions ranging from 6 to 20 kb that eliminated the promoter region of the gene. The fourth mRNA-allele did not contain any deletion or alteration in the promoter sequence; the reason for the mRNA-phenotype was not apparent. Nine alleles were positive for mRNAs, of which three encoded mRNAs of abnormal size. One of the abnormal mRNAs was produced by a gene harboring a deletion, and another was produced by a gene with a complex rearrangement. The third abnormal-sized mRNA (3.1 kb larger than normal) was produced by an allele that had no detectable alterations as judged by Southern blotting. The other six mRNA' alleles appeared normal by Southern blotting and produced normal-sized mRNA but no receptor protein. The current studies demonstrate that mRNA analysis coupled with haplotype determination by Southern blot analysis can be used to classify crm mutations at a genetic locus where multiple alleles exist.
Introduction
Familial hypercholesterolemia (FH)' is an autosomal dominant disorder caused by mutations in the gene for the LDL receptor (1) . This cell-surface receptor carries out two important functions in maintaining cholesterol homeostasis (2). First, it supplies cells with cholesterol for membrane synthesis by binding to plasma LDL particles and bringing them into the cell by receptor-mediated endocytosis. Second, the receptor Received for publication 22 July 1987 and in revised form 22 September 1987.
1. Abbreviations used in this paper: crm-, negative for crossreacting material; FH, familial hypercholesterolemia; RFLP, restriction fragment length polymorphism. helps to maintain low plasma levels of these potentially atherogenic particles by clearing them from the circulation. A mutation in one LDL receptor gene is found in about 0.2% of individuals in most populations (1) . These individuals, who are designated FH heterozygotes, produce one-halfthe normal number of LDL receptors, and consequently they have plasma LDL-cholesterol levels that are approximately twice the normal value. The increase in plasma LDL leads to premature atherosclerosis and an increased incidence of myocardial infarction in the fourth and fifth decades. In subjects with homozygous FH, both LDL receptor alleles bear mutations, the number of functional LDL receptors is severely reduced, and plasma LDL levels are more than five times higher than normal. Homozygous FH is found in one in one million individuals and is usually fatal before the age of 30, owing to coronary atherosclerosis (1) .
The LDL receptor has been purified to homogeneity (3) , and antireceptor monoclonal antibodies have been developed (4) . When used as probes, these antibodies have revealed that FH is genetically heterogeneous (5, 6) . At least four different classes of mutations can be distinguished. These disrupt synthesis, intracellular transport, LDL binding ability, or internalization of the LDL receptor (2, 7). Recently, we have isolated cloned DNAs corresponding to the human LDL receptor mRNA (8) and gene (9) . Studies using these DNA probes have revealed that the LDL receptor gene spans about 45 kb of DNA on the distal short arm of chromosome 19 (9, 10) . The gene is divided into 18 exons and 17 introns (9) and encodes a mature mRNA of 5.3 kb (8) .
Through cloning and DNA sequencing, we have begun to analyze the molecular basis ofthe four classes ofFH mutations (1 1-18) . One class whose study is particularly facilitated by the availability ofDNA probes are those that block the synthesis of the LDL receptor protein (so-called class 1 mutations). These mutations are referred to as crm-alleles since they fail to produce cross-reacting material (crm) when studied immunologically. The availability of cloned DNAs allows one to define the RNA phenotype of a crm allele and to assess directly its genotype.
In the current studies, we have undertaken an extensive survey of crm-alleles using both (19) . Maximal synthesis of LDL receptors was induced by incubation in human lipoprotein-deficient serum for 16 h before study (19) . For radiolabeling, the cells were preincubated in methionine-free DME for 30 min and then pulse-labeled with [35S]methionine (90-110 gCi/ml) for 2 h at 370C in the same medium. The cells were then incubated in complete medium for 2 h at 370C (6) . LDL receptors were immunoprecipitated from detergent-solubilized cell extracts with a monoclonal antibody (IgG-C7) directed against the ligand binding domain of the LDL receptor (6) . As a control, an irrelevant monoclonal antibody (IgG-2001) was also employed (6) . The immunoprecipitates were subjected to SDS-PAGE under reducing conditions and autoradiography was performed as described (6) . Apparent molecular weights of the "S-labeled proteins were calculated from the migration positions of marker proteins (6) .
Southern blotting analysis. Genomic DNA was isolated from cultured fibroblasts or peripheral blood as described (15) and digested for at least 2 h with 5-10 U of restriction enzyme per,ug of DNA in the presence of the buffer suggested by the manufacturer. After quantification by a fluorescence assay (20) RNA blotting analysis. Diploid human fibroblasts were cultured and induced for maximum expression of LDL receptors using a previously described protocol (17) . Total RNA was isolated from cells by a guanidinium HC1 procedure and analyzed by blotting after electrophoresis in glyoxal-containing agarose gels. Conditions for hybridization, probe synthesis, and washing were as described previously (17) .
Haplotype analysis. DNA samples were digested with each of the restriction enzymes known to result in polymorphic patterns and analyzed by Southern blotting with the appropriate probes. Previously reported restriction enzymes that reveal restriction fragment length polymorphisms (RFLPs) in the LDL receptor gene include: Stu 1(22), Pvu 11 (23, 24) , Ava 11 (25) , Apa LI (26), PstI (27) , and Nco 1 (28) . In addition, three previously unreported DNA polymorphisms for the enzymes Bsm I, SphI, and Spe I were analyzed (Leitersdorf, E., J. L. Goldstein (Fig. 1 A) . 16 Fig. 1, A Fig. 2 B) , a faint band of 8 kb is seen. We believe that this RNA represents an incompletely spliced nuclear RNA since its amount varies from nondetectable to trace in different preparations of RNA from a single individual.
In an effort to determine which cram individuals harbor the same mutation, the RFLP haplotypes ofthe chromosomes were analyzed (Table II) . Genomic DNA was isolated from fibroblasts and digested separately with multiple restriction enzymes known to reveal 10 RFLPs. The frequency of the least common allele at each RFLP site varies from 5 to 47% in the general American white population, and most individuals from nonconsanguineous matings are heterozygous at more than one of these loci (Leitersdorf, E., et al., manuscript in preparation). The results from the 32 crm FH chromosomes are summarized in Table II . In some instances a deletion in the gene on one or both homologues prevented the ascertainment of certain polymorphic sites (indicated by the asterisks in Table II ). 13 ofthe 16 patients were homozygous at all RFLPs examined, thus allowing an unambiguous assignment of haplotype. These haplotypes are designated a through m in Tables   I and II . Three subjects (FH 26, 132, and 790) were heterozygous at one or more RFLP sites. Although a precise haplotype assignment could not be made in these cases, we gave each of them two letter designations in Tables I and II to indicate that two different haplotypes were present. Using this scheme, we were able to demonstrate the existence among these subjects of 13 distinct LDL receptor haplotypes. Inasmuch as mutations in genes appear to arise after the formation of RFLP haplotypes (see below), these data suggest the existence of at least 13 separate crm-alleles at the LDL receptor locus.
Southern blotting experiments revealed four different gross deletions of the LDL receptor gene among the crm-subjects. One deletion, which prevents expression of LDL receptor mRNA, has been described previously at the molecular level (29) . This deletion is found in a majority of French Canadians with FH. Another deletion, also associated with an absence of mRNA (Fig. 2) , was detected in FH 26, an American who had two different haplotypes (Table II) (Fig. 3) . In the normal DNA, a fragment of9 kb was detected (fragment A, Fig. 3 ), which was derived from an Xba I site in intron 1, and a Kpn I site in intron 2. This same fragment was present in the FH 26 DNA together with an abnormal fragment of -13 kb (fragment C, Fig. 3 ). As diagramed in Fig. 3 , analysis of the previously determined restriction map in this region of the gene (9) together with additional experiments (not shown) suggested that fragment C in the FH 26 DNA was produced by a deletion of -6 kb spanning exon 1 and the Xba I site in intron 1. The 5' end of this fragment was derived from an Xba I site in the 5'-flanking region of the gene, and the 3' end was derived from the Kpn I site in intron 2 (Fig. 3) Analysis ofDNA from the parents ofFH 26 confirmed that she was a compound heterozygote who inherited the gene with the 6-kb deletion from her father and a different mutant allele from her mother (Fig. 3) . This maternal allele showed no detectable difference from the normal allele in Southern blotting experiments.
As shown in Fig. 4 , a third type of deletion was detected by Southern blotting in FH 651, an individual of Italian descent. When DNA from a normal subject and from FH 651 was digested with Xba I and then analyzed with a probe derived from exon 15, two different fragments were visualized. DNA from the normal individual contained a fragment of 12 kb derived from Xba I sites in intron 12 and intron 15, whereas DNA from FH 651 contained a fragment of 8 kb which was derived from these same Xba I sites, but apparently contained an internal 4-kb deletion (Fig. 4) (17) and one probe complementary to the human fl-actin mRNA (38) . After hybridization, the filters were washed and used to expose Kodak XAR-5 film at -70'C with DuPont Cronex Lightning Plus intensifying screens. Exposure times varied from 24 to 72 h for the different panels (A-E).
tion harbored by FH 651 resembles an FH mutation that was recently cloned by Humphries and his colleagues (30, 31) . Fig. 5 shows the restriction digests ofthe DNA ofFH 132, a compound heterozygote with gross structural alterations of each receptor allele. The results yielded a complex pattern of restriction fragments that was difficult to interpret in a definitive way. Digestion of normal DNA with Eco RV and analysis with an exon 7 probe revealed a fragment of -23 kb. This normal fragment plus a novel DNA band of -5 kb were detected in FH 132 (Fig. 5 A) . When (Fig. 5 B) . The normal 23-kb band was derived from an Eco RI site in intron 10 and a site in the 3'-flanking region of the gene. Additional blotting experiments (data not shown) using Eco RI and probes derived from exons [13] [14] [15] [16] [17] [18] French Canadian ** --
French Canadian ** -- (Fig. 2) . The 6.2-kb mRNA hybridized with cDNA probes from both exon 4 and exon 17 (data not shown). If the 6.2-kb transcript originated from one of two alleles with a deletion, it would be expected to hybridize to Total genomic DNA (5 4g) from the indicated individual was digested with Kpn I and Xba I, subjected to electrophoresis in 0.8% agarose, transferred to a nylon membrane, and hybridized to a 32p_ labeled probe derived from exon 2 of the normal LDL receptor gene.
After washing as described in Methods, the filter was used to expose Kodak XAR-5 film for 48 h at -70'C in the presence of an intensifying screen. The visualized fragments are designated A, B, and C. Molecular only one of these probes. Thus, the RNA analysis is most consistent with the 6.2-kb transcript arising from an allele harboring a complex rearrangement, possibly a partial duplication involving exons 7-12. This model implies that the other FH 132 allele is deleted completely or nearly completely in its entirety. This observation is supported by two other lines of evidence: (a) in Southern blots in which probes from exons 1 and 6 were used, the intensity ofthe normal bands was approximately one-half the intensity that would be expected from the amount of DNA that was loaded, implying that FH 132 had only single copy of these exons (data not shown); and (b) the FH 132 DNA showed only a single band at each of the 10 RFLP sites (Table II) , even though this subject would be expected to have two different haplotypes based on the fact that she is a compound heterozygote. The complex rearrangement in the expressed allele of FH 132 probably involves a partial duplication ofthe gene. Definitive analysis will require cloning and sequencing of the two abnormal alleles.
Discussion
The analysis of fibroblasts from subjects with the homozygous form of FH has revealed at least four broad classes of mutations that disrupt the synthesis, intracellular transport, and binding and internalization functions of the LDL receptor (2, 7). Here, we have characterized at the molecular level one of these classes, namely, the mutations in which the synthesis of immunodetectable receptor protein is abolished (crn-alleles). We have used a composite approach employing RNA blot hybridization to determine the presence of receptor mRNA and Southern blot analysis to search for deletions in the gene and to ascertain the RFLP haplotype on which the mutations occur. Among the 132 FH homozygote fibroblast strains that crnf Alleles at Low Density Lipoprotein Receptor Locus 913 were analyzed, 16 have two crm, genes. Fibroblast strains from one ofthese subjects were not available for RNA analysis and so the current studies represent an analysis of the 30 crmgenes in the remaining 15 patients. The results of this analysis are summarized in Fig. 6 . The current studies were performed with a monoclonal antibody that recognizes the first cysteine-rich repeat in the ligand binding domain of the LDL receptor (32). It is possible that some ofthe crm-cell strains that contain mRNA produce an altered LDL receptor protein that lacks the epitope recognized by this antibody. Against this possibility is the previous demonstration that one cell line, FH 664, fails to produce a protein that is recognized by a polyclonal anti-receptor antibody (6) . As described below, FH 664 is one of the three patients who is homozygous for the f haplotype and produces a normal-sized mRNA (Table I) . Moreover, among the deletion-bearing genes that are mRNA', none has a deletion that removes the coding region for the epitope recognized by the monoclonal antibody.
The assignment of RFLP haplotypes was made possible by the presence of 10 polymorphic restriction fragment sites in or near the LDL receptor gene. Thirteen of the crm-subjects were homozygous at all 10 restriction sites (Tables I and II) , thus allowing unambiguous assignment of the haplotype of each of these chromosomes without the necessity of studying chromosomes from family members. Homozygosity for RFLPs in these patients suggests that each of them has inherited two copies of the same mutant gene, presumably as a result of common ancestry, even though consanguinity was usually denied.
In taking advantage ofthe haplotype analysis to classify the mutant alleles, we have based our conclusions on previous analyses of the f3-globin gene locus (33) and the phenylalanine hydroxylase locus (34, 35) . These studies have shown that the RFLP haplotypes of the chromosomes antedate the mutations in the genes. In general, each mutation occurs upon the background of a different RFLP haplotype. If two mutant genes have different haplotypes, then it is likely that the two genes bear different mutations, especially if the haplotypes differ at more than one RFLP site.
Using the above criteria, we can first divide the 30 crmn genes into two classes: those that fail to produce mRNA and those that produce mRNA (Fig. 6) . We can then use the deletion analysis and haplotype assignment to estimate the number ofdifferent alleles within each class. Eleven ofthe genes are of the mRNA-type, and these comprise four different mutant alleles. Three of the four mRNA-alleles contain deletions that include the promoter, and these account for 10 of the 11 mRNA-genes. 8 of these 10 genes occurred in homozygous form in individuals of French Canadian descent (Tables I and  II) . We have previously shown that this mutant allele contains a deletion that removes more than 10 kb ofthe gene, including the promoter (29) . A second promoter deletion was found in subject FH 26, a genetic compound who had two different RFLP haplotypes that were associated with two different mRNA-alleles (Tables I and II) . One ofthe mRNAM alleles in FH 26 contained a 6-kb deletion that removed the promoter (Fig. 3) . The other allele in FH 26 contained no visible deletion and is discussed below. A third promoter deletion occurred in FH 132, another genetic compound. The size of the deleted region cannot be conclusively determined from the available data, but appears to involve most of the gene, including the promoter region.
Among the four mRNA-alleles, only one was of the nondeletion type (Fig. 6) . This was the second allele present in FH 26 (Fig. 3) . All regions of this gene appeared normal in Southern blots. Moreover, in experiments using a gene-amplification technique (36), we found that the sequence of the immediate 5' flanking region ofthe gene was normal (Russell, D. W., unpublished observations). This sequence contains all of the signals that are known to be necessary for transcription (37) . The mRNA-phenotype from this allele must be attributable either to improper processing of the mRNA or to some instability in its structure. Table I) was omitted from this analysis because measurements of receptor mRNA could not be obtained, owing to a lack of availability of cultured fibroblasts.
crm-Alleles at Low Density Lipoprotein Receptor Locus 915
All of the FH homozygotes in the mRNA-category who were homozygous for a visible deletion were also homozygous for their RFLP haplotypes. For example, the French Canadians all had the aa haplotypes (Table II) . In contrast, the FH homozygote who had two different mutations (FH 26) was heterozygous for her RFLP haplotypes. FH 132, a compound heterozygote, appeared to be homozygous at each RFLP site, most likely because one of her alleles has a large deletion, as discussed above. All of the haplotypes in these latter two patients were different from each other, and they also differed from the haplotypes in the French Canadian individuals (Table II) . These data support the notion that each mutation in the LDL receptor gene arose on the background of a specific RFLP haplotype and that the haplotype antedated the mutation.
Among the 30 genes with a crm-phenotype, 19 were mRNA+ (Fig. 6 ). These 19 genes could be subdivided into nine alleles, three of which produced mRNAs of abnormal size. One ofthese latter alleles occurred in homozygous form in FH 65 1, who synthesized an mRNA of 5.0 kb as a consequence of a deletion that removed exon 13 and 14. Inasmuch as exons 13 and 14 account for -300 bp of the normal 5.3-kb LDL receptor mRNA (9) , the size of the FH 651 mRNA (5.0 kb) is consistent with the splicing of exon 12 to exon 15. Such an event would shift the translation reading frame of the deleted mRNA and result in a truncated protein that terminates after 48 bp of the exon 15 sequence (8, 9, 31) . We have previously characterized a mutation in a subject known as FH 381, in which a deletion of 5 kb joined exon 13 to a portion of intron 15 (14) . Although a shortened mRNA was present in FH 381, we were unable to detect any truncated LDL receptor protein within the cells or in the culture medium, which suggests that this protein was rapidly degraded. (FH 381 is not included in the current analysis because she is the heterozygous mother of a compound heterozygote in whom the second mutant allele produced an immunoprecipitable protein [13] ). A similar explanation of protein instability can be invoked to explain the crm-phenotype of FH 65 1.
The second RNA' allele occurred in FH 132, who produced an mRNA of 6.2 kb that was derived from a gene harboring a complex rearrangement in one of the two alleles. The third RNA+ allele occurred in patient FH 551. This individual, who is homozygous at all ten RFLP sites, produced both an abnormally sized receptor mRNA (major product) and a normally sized mRNA (minor product). The genesis of the abnormal 8.4-kb mRNA in this homozygous subject is most readily attributable to a splicing defect. Southern blotting of genomic DNA revealed no alterations in gene structure. These results suggest that a small insertion, deletion, or point mutation may have altered a splice donor or acceptor site, giving rise primarily to an elongated mRNA. The latter mRNA could encode a very small protein or an unstable protein, thus explaining the crm-phenotype.
The remaining six RNA+ alleles analyzed in this study synthesized an LDL receptor mRNA that was apparently normal in size (Fig. 6) Colombia. The frequency of the f haplotype in white Americans is -30% (Leitersdorf, E., et al., manuscript in preparation). It is possible that these three patients have the same mutation and that this mutation is a fairly common one among FH patients. However, since the f haplotype is common, it is also possible that these three patients have different mutations that have all occurred on the same haplotype background.
